Venus Concept Inc. (VERO)
After hours:
| Previous Close | 0.8072 |
| Open | 0.7598 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 0.7209 - 0.7864 |
| 52 Week Range | 0.6020 - 4.7000 |
| Volume | |
| Avg. Volume | 563,269 |
| Market Cap | 4.581M |
| Beta (5Y Monthly) | 0.58 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -6.8400 |
| Earnings Date | May 15, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 10.60 |
GlobeNewswireVenus Concept Announces Loan Purchase and Completion of First Phase of Refinancing
MSLP Loan Purchase and Short-term Bridge Financing of Up To $5.0 million By Madryn Asset ManagementTORONTO, April 24, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that on April 23, 2024, its existing Main Street Lending Program Loan (“MSLP Loan”) was purchased by affiliates of Madryn Asset Management, LP (“Madryn”) for an undisclosed amount from the City National Bank of Florida (“CNB”
- GlobeNewswire
Venus Concept to Release First Quarter of Fiscal Year 2024 Financial Results on May 15, 2024
TORONTO, April 15, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that first quarter of fiscal year 2024 financial results will be released before the market opens on Wednesday, May 15, 2024. Management will host a conference call at 8:00 a.m. Eastern Time on May 15, 2024, to discuss the results of the quarter with a question and answer session. Those who would like to participate may di
- GlobeNewswire
Venus Concept Announces Israeli Regulatory Approval for Venus Bliss MAX
TORONTO, April 08, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has received approval for the Venus Bliss MAX from the State of Israel Ministry of Health. The Venus Bliss MAX was first launched commercially in the United States in Q1 2022 after FDA 510(k) clearance and offered internationally in approved jurisdictions. The Venus Bliss MAX offers three advanced technologies in o
